Ijaz S - Search Results

1

Boosting understanding of Lassa Fever virus epidemiology: Field testing a novel assay to identify past Lassa Fever virus infection in blood and oral fluids of survivors and unexposed controls in Sierra Leone.

Akpogheneta O, Dicks S, Grant D, Kanneh Z, Jusu B, Edem-Hotah J, Kanneh L, Alhasan F, Gbakie M, Schieffelin J, Ijaz S, Tedder R, Bower H. Akpogheneta O, et al. Among authors: ijaz s. PLoS Negl Trop Dis. 2021 Mar 31;15(3):e0009255. doi: 10.1371/journal.pntd.0009255. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33788861 Free PMC article.

2

Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.

Ijaz S, Torre F, Tedder RS, Williams R, Naoumov NV. Ijaz S, et al. J Med Virol. 2001 Mar;63(3):210-6. doi: 10.1002/1096-9071(200103)63:3<210::aid-jmv1002>3.0.co;2-c. J Med Virol. 2001. PMID: 11170059 Clinical Trial.

3

Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers.

Tedder RS, Ijaz S, Gilbert N, Barbara JA, Corden SA, Gilson RJ, Boxall EH. Tedder RS, et al. Among authors: ijaz s. J Med Virol. 2002 Dec;68(4):505-12. doi: 10.1002/jmv.10241. J Med Virol. 2002. PMID: 12376958

4

A 'first loop' linear epitope accessible on native hepatitis B surface antigen that persists in the face of 'second loop' immune escape.

Ijaz S, Ferns RB, Tedder RS. Ijaz S, et al. J Gen Virol. 2003 Feb;84(Pt 2):269-275. doi: 10.1099/vir.0.18667-0. J Gen Virol. 2003. PMID: 12560557

5

Characterization of hepatitis B surface antigen strains circulating in the Kingdom of Cambodia.

Srey CT, Ijaz S, Tedder RS, Monchy D. Srey CT, et al. Among authors: ijaz s. J Viral Hepat. 2006 Jan;13(1):62-6. doi: 10.1111/j.1365-2893.2005.00656.x. J Viral Hepat. 2006. PMID: 16364084

6

A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.

Ijaz S, Khulan J, Bissett SL, Ferns RB, Nymadawa P, Tedder RS. Ijaz S, et al. J Med Virol. 2006 Dec;78(12):1554-9. doi: 10.1002/jmv.20738. J Med Virol. 2006. PMID: 17063521

7

Transmission of hepatitis B virus (genotype E) in a haemodialysis unit.

Ramalingam S, Leung T, Cairns H, Sibley P, Smith M, Ijaz S, Tedder R, Zuckerman M. Ramalingam S, et al. Among authors: ijaz s. J Clin Virol. 2007 Oct;40(2):105-9. doi: 10.1016/j.jcv.2007.07.012. Epub 2007 Sep 7. J Clin Virol. 2007. PMID: 17826313

8

Non-A hepatitis B virus genotypes in antenatal clinics, United Kingdom.

Dervisevic S, Ijaz S, Chaudry S, Tedder RS. Dervisevic S, et al. Among authors: ijaz s. Emerg Infect Dis. 2007 Nov;13(11):1689-93. doi: 10.3201/eid1311.070578. Emerg Infect Dis. 2007. PMID: 18217552 Free PMC article.

9

Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.

Ijaz S, Arnold C, Dervisevic S, Mechurova J, Tatman N, Tedder RS, Naoumov NV. Ijaz S, et al. J Med Virol. 2008 Jul;80(7):1160-70. doi: 10.1002/jmv.21206. J Med Virol. 2008. PMID: 18461609 Clinical Trial.

10

Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.

Sloan RD, Ijaz S, Moore PL, Harrison TJ, Teo CG, Tedder RS. Sloan RD, et al. Among authors: ijaz s. Antivir Ther. 2008;13(3):439-47. Antivir Ther. 2008. PMID: 18572757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters